Download Powerpoint - Blood Journal

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Blood bank wikipedia , lookup

Hemorheology wikipedia , lookup

Lymphopoiesis wikipedia , lookup

Transcript
Dendritic cells are functionally defective in multiple
myeloma: the role of interleukin-6
by Marina Ratta, Francesco Fagnoni, Antonio Curti, Rosanna Vescovini, Paolo
Sansoni, Barbara Oliviero, Miriam Fogli, Elisa Ferri, Gioacchino Robustelli Della
Cuna, Sante Tura, Michele Baccarani, and Roberto M. Lemoli
Blood
Volume 100(1):230-237
July 1, 2002
©2002 by American Society of Hematology
Alloreactivity of circulating DCs (PBDCs) and DCs derived from CD14+ monocytes (Mo-DC) from
the same MM patients and of PBDCs from healthy subjects.Increasing numbers of DCs were
tested for their capacity to stimulate 5 × 104 allogeneic CD3+ cells.
Marina Ratta et al. Blood 2002;100:230-237
©2002 by American Society of Hematology
Capability of PBDCs and Mo-DCs from the same MM patients and of PBDCs from healthy
subjects to present soluble antigens to autologous T cells.CD3+ cells (1 × 105) were incubated
with either a fixed number (3000) of DCs (A) or increasing numbers of DCs (B).
Marina Ratta et al. Blood 2002;100:230-237
©2002 by American Society of Hematology
Differentiation of DCs derived from CD34+ cells is inhibited by IL-6.CD34+ progenitor cells were
incubated with GM-CSF, TNF-α, SCF, and FLT3-L (G+T+S+F) with or without IL-6.
Marina Ratta et al. Blood 2002;100:230-237
©2002 by American Society of Hematology
Addition of IL-6 resulted in maintenance of DC high phagocytic capacity.CD34+ cells were
cultured for 12 to 14 days with GM-CSF, TNF-α, SCF, and FLT3-L (G+T+S+F) with or without IL-6.
Marina Ratta et al. Blood 2002;100:230-237
©2002 by American Society of Hematology
Alloreactivity of myeloma DCs derived from CD34+ cells generated in the presence of GM-CSF,
TNF-α, SCF, and FLT3-L (G+T+S+F) and grown in FCS (A) or autologous serum (B) with and
without IL-6.Increasing numbers of DCs were tested for their capacity to stimu...
Marina Ratta et al. Blood 2002;100:230-237
©2002 by American Society of Hematology
Effect of IL-6 on the antigen-presenting ability (to autologous cells) of myeloma DCs derived
from CD34+progenitors in the presence of GM-CSF, TNF-α, SCF, and FLT3-L (G+T+S+F) and
grown in FCS (A) or autologous serum (B).CD3+ cells (1 × 105) were incubated ...
Marina Ratta et al. Blood 2002;100:230-237
©2002 by American Society of Hematology